FDA NDC Directory · JSON-LD · Markdown

Atovaquone Oral Suspension

NDC 10702-223 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameAtovaquone
Labeler / ManufacturerKVK-Tech, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210510
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started20190329
Package count1

External sources

Source: openFDA. Public-domain (CC0).